atazanavir sulfate has been researched along with alendronate in 1 studies
Studies (atazanavir sulfate) | Trials (atazanavir sulfate) | Recent Studies (post-2010) (atazanavir sulfate) | Studies (alendronate) | Trials (alendronate) | Recent Studies (post-2010) (alendronate) |
---|---|---|---|---|---|
1,102 | 246 | 590 | 4,096 | 731 | 1,724 |
Protein | Taxonomy | atazanavir sulfate (IC50) | alendronate (IC50) |
---|---|---|---|
Chain A, farnesyl pyrophosphate synthase | Trypanosoma cruzi | 147 | |
Farnesyl pyrophosphate synthase | Homo sapiens (human) | 0.7523 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Boska, MD; Bronich, TK; Edagwa, B; Gendelman, HE; Li, T; Liu, XM; McMillan, JM; Puligujja, P; Zhang, G | 1 |
1 other study(ies) available for atazanavir sulfate and alendronate
Article | Year |
---|---|
Magnetic resonance imaging of folic acid-coated magnetite nanoparticles reflects tissue biodistribution of long-acting antiretroviral therapy.
Topics: Alendronate; Animals; Anti-Retroviral Agents; Atazanavir Sulfate; Dextrans; Drug Delivery Systems; Folic Acid; Macrophages; Magnetic Resonance Imaging; Magnetite Nanoparticles; Male; Mice; Mice, Inbred BALB C; Molecular Targeted Therapy; Mononuclear Phagocyte System; Nanomedicine; Reproducibility of Results; Tissue Distribution | 2015 |